$295 Million is the total value of HARBOURVEST PARTNERS LLC's 58 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| W | Wayfair Inc. | $64,332,972 | -6.8% | 1,062,126 | 0.0% | 21.84% | +11.4% | |
| Toast, Inc. | $42,758,305 | -17.0% | 2,282,878 | 0.0% | 14.52% | -0.8% | ||
| Omega Therapeutics, Inc. | $7,551,037 | -61.6% | 3,512,110 | 0.0% | 2.56% | -54.1% | ||
| YMM | Full Truck Alliance Co. Ltd.sponsored ads | $6,741,363 | +13.2% | 957,580 | 0.0% | 2.29% | +35.3% | |
| Hesai Groupsponsored ads | $6,060,610 | -5.0% | 606,061 | 0.0% | 2.06% | +13.5% | ||
| HashiCorp, Inc. | $4,779,027 | -12.8% | 209,331 | 0.0% | 1.62% | +4.2% | ||
| LC | LendingClub Corp. | $3,131,984 | -37.4% | 513,440 | 0.0% | 1.06% | -25.2% | |
| PGNY | Progyny, Inc. | $3,050,029 | -13.5% | 89,654 | 0.0% | 1.04% | +3.4% | |
| SPOT | Spotify Technology S.A. | $2,592,694 | -3.7% | 16,766 | 0.0% | 0.88% | +15.0% | |
| NARI | Inari Medical | $2,520,516 | +12.5% | 38,540 | 0.0% | 0.86% | +34.6% | |
| RLAY | Relay Therapeutics, Inc. | $2,492,741 | -33.0% | 296,402 | 0.0% | 0.85% | -20.0% | |
| ACVA | ACV Auctions, Inc. | $2,232,705 | -12.1% | 147,082 | 0.0% | 0.76% | +5.1% | |
| BE | Bloom Energy Corporation | $2,150,759 | -18.9% | 162,199 | 0.0% | 0.73% | -3.1% | |
| Amplitude Inc. | $1,770,418 | +5.2% | 153,018 | 0.0% | 0.60% | +25.7% | ||
| FROG | Jfrog Ltd. | $1,496,443 | -8.4% | 59,008 | 0.0% | 0.51% | +9.5% | |
| ZUO | Zuora, Inc. | $1,350,487 | -24.9% | 163,894 | 0.0% | 0.46% | -10.2% | |
| U | Unity Software | $1,073,350 | -27.7% | 34,194 | 0.0% | 0.36% | -13.7% | |
| DOCN | Digital Ocean, Inc. | $1,062,366 | -40.1% | 44,210 | 0.0% | 0.36% | -28.4% | |
| DOCS | Doximity, Inc. | $1,056,841 | -37.6% | 49,804 | 0.0% | 0.36% | -25.4% | |
| EB | Eventbrite, Inc. | $1,007,337 | +3.2% | 102,164 | 0.0% | 0.34% | +23.5% | |
| FTCH | Farfetch Ltd.ordinary shares cla | $925,276 | -65.4% | 442,716 | 0.0% | 0.31% | -58.6% | |
| PLRX | Pliant Therapeutics, Inc. | $857,186 | -4.3% | 49,434 | 0.0% | 0.29% | +14.6% | |
| TWLO | Twilio, Inc. | $852,899 | -8.0% | 14,572 | 0.0% | 0.29% | +10.3% | |
| DIBS | 1stdibs.com, Inc. | $726,165 | -2.7% | 199,496 | 0.0% | 0.25% | +16.5% | |
| HNST | The Honest Company Inc. | $599,293 | -25.0% | 475,629 | 0.0% | 0.20% | -10.6% | |
| PINS | Pinterest, Inc. | $576,009 | -1.1% | 21,310 | 0.0% | 0.20% | +18.8% | |
| IBRX | ImmunityBio, Inc. | $567,348 | -39.2% | 335,709 | 0.0% | 0.19% | -27.2% | |
| CPNG | Coupang Inc. | $456,178 | -2.3% | 26,834 | 0.0% | 0.16% | +16.5% | |
| Bright Health Group, Inc. | $314,738 | -51.1% | 52,720 | 0.0% | 0.11% | -41.5% | ||
| DASH | DoorDash, Inc. | $199,072 | +4.0% | 2,505 | 0.0% | 0.07% | +25.9% | |
| PACB | Pacific Biosciences of California, Inc. | $196,091 | -37.2% | 23,484 | 0.0% | 0.07% | -24.7% | |
| RPTX | Repare Therapeutics, Inc. | $148,294 | +14.2% | 12,276 | 0.0% | 0.05% | +35.1% | |
| OPEN | Opendoor Technologies Inc. | $123,306 | -34.3% | 46,707 | 0.0% | 0.04% | -20.8% | |
| MCRB | Seres Therapeutics, Inc. | $117,484 | -50.3% | 49,363 | 0.0% | 0.04% | -40.3% | |
| Rallybio Holdings, LLC | $73,725 | -40.5% | 21,877 | 0.0% | 0.02% | -28.6% | ||
| PMVP | PMV Pharmaceuticals | $70,813 | -1.9% | 11,533 | 0.0% | 0.02% | +14.3% | |
| IPSC | Century Therapeutics, Inc. | $58,036 | -36.7% | 29,018 | 0.0% | 0.02% | -23.1% | |
| ALGS | Aligos Therapeutics, Inc. | $14,031 | -23.1% | 18,783 | 0.0% | 0.01% | 0.0% | |
| NXTC | NextCure, Inc. | $12,957 | -28.3% | 10,044 | 0.0% | 0.00% | -20.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
| 13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.